Mike EmletSarah Gammage
Stories from Saints, Sufferers, & Sinners – Episode 3: Sarah
February 25, 2021
0:00
0:00
Mike EmletSarah Gammage
February 25, 2021
Their flagship product in this vertical, , is a synthetic analog of Thyrotropin-releasing hormone (TRH) designed to treat Treatment-Resistant Depression (TRD). Early Phase I trials (leaked via clinical trial registries) suggest a rapid-onset antidepressant effect without the psychedelic side effects of ketamine.
Sign up for our weekly email and receive access to 5 conference sessions on the topic of marriage.
Loading form...
